| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0003 | 1 |